SCHEMBL6837809

SCHEMBL6837809

COc1ccc(C(N)C(C)c2ccccc2)c2cc(C(=O)Nc3ccc(C(C)(C)C)cc3)oc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
DUSP3 P51452 1/20 0.44
PTPN11 Q06124 1/20 0.44
MAPT P10636 6/20 0.43
TP53 P04637 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 2/20 0.41
RAB9A P51151 2/20 0.41
HTT P42858 2/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
NR1H4 Q96RI1 5/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837563 0.90 MAPT (0.49) KMT2ADUSP3PTPN11MAPTTP53
SCHEMBL6837919 0.89 KMT2A (0.49) KMT2ADUSP3PTPN11MAPTTP53
SCHEMBL6837921 0.89 KMT2A (0.49) KMT2ADUSP3PTPN11MAPTTP53
SCHEMBL6837490 0.84 THRB (0.52) KMT2AMAPTTP53SMN1; SMN2NPSR1
SCHEMBL7145916 0.82 ALDH1A1 (0.49) KMT2AMAPTSMN1; SMN2LMNANPSR1
SCHEMBL7145923 0.82 ALDH1A1 (0.49) KMT2AMAPTSMN1; SMN2LMNANPSR1
SCHEMBL6833122 0.81 PDE4A (0.42) KMT2AMAPTTP53SMN1; SMN2LMNA
SCHEMBL6837934 0.81 HTT (0.46) KMT2ATP53SMN1; SMN2LMNANPSR1
SCHEMBL6837813 0.80 NR1H4 (0.43) KMT2ADUSP3PTPN11MAPTTP53
SCHEMBL6944130 0.78 NPC1 (0.42) KMT2ASMN1; SMN2ALDH1A1MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 KMT2A 4289/4885DUSP3 4545/4885PTPN11 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.